- Laboratory
- Laboratory medicine
- COVID-19 test kit
- Shenzhen Yhlo Biotech Co., Ltd.
- Company
- Products
- Catalogs
- News & Trends
- Exhibitions
Neutralizing antibody test kit iFlashCOVID-19immunitySARS-COV-2
Add to favorites
Compare this product
Characteristics
- Applications
- COVID-19, immunity
- Tested parameter
- for neutralizing antibody
- Micro-organism
- SARS-COV-2
- Sample type
- clinical, serum, plasma
- Analysis mode
- chemiluminescent immunoassay, chemiluminescence
Description
iFlash-2019-nCoV NAb (Neutralization Antibody) assay is a chemiluminescence immunoassay (CLIA) for the qualitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.
Clinical Benefits:
Evaluate COVID-19 vaccines development and efficacy
Monitor the NAb titers in COVID-19 patients and vaccinated individuals.
Analyze herd immunity status to guide policymakers.
Monitoring during convalescent plasma therapy or other antibody-related treatments.
Catalogs
Other Shenzhen Yhlo Biotech Co., Ltd. products
COVID-19
Related Searches
- Reagent kit
- Assay kit
- Solution reagent kit
- Blood assay kit
- Serum assay kit
- Immunoassay assay kit
- Liquid reagent kit
- Plasma assay kit
- Research reagent kit
- Diagnostic reagent kit
- Laboratory reagent kit
- Rapid lateral flow test
- Blood rapid diagnostic test
- Infectious disease assay kit
- Immunoassay rapid diagnostic test
- Respiratory infection test kit
- Virus rapid diagnostic test
- Whole blood detection kit
- Cassette rapid diagnostic test
- Histology reagent kit
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.